Effects of tDCS and VNS on Postoperative Analgesia
Launched by COLUMBIA UNIVERSITY · Aug 12, 2024
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two treatments, transcranial direct current stimulation (tDCS) and Afferent Vagus nerve stimulation (VNS), to see if they can help reduce pain after surgery. The study will involve adults who are having elective surgeries that require general anesthesia. Researchers will measure how much pain patients feel, along with other important health signs, and track how much pain medicine they need in the first 24 hours after surgery.
To participate, you need to be at least 18 years old and able to give consent. However, some people won’t be eligible, such as those with certain heart conditions, pregnant individuals, or those with a history of seizures. If you join the study, you will be placed in one of four groups, where you may receive either the active treatment, a fake version of the treatment, or both. This trial is not yet recruiting participants, so you'll want to keep an eye out for when it begins if you're interested.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 years or above with the capacity to provide informed consent who are undergoing an elective surgery requiring general anesthesia
- Exclusion Criteria:
- • cardiac bradyarrhythmia: taking beta-blockers;
- • patients with metal implants around the chest, neck, or head (e.g. implantable pacemakers and defibrillators, deep brain stimulation devices);
- • pregnancy
- • history of epilepsy or seizures.
- • patients undergoing surgical procedures involving the head, neck or spine, or those requiring the use of cardiopulmonary bypass
About Columbia University
Columbia University, a prestigious Ivy League institution located in New York City, is a leading sponsor of clinical trials dedicated to advancing medical research and improving patient care. With a robust network of research facilities and a commitment to innovation, Columbia University collaborates with a diverse range of healthcare professionals and researchers to explore groundbreaking therapies and treatment methodologies. The university's clinical trials encompass various fields, including oncology, neurology, and public health, aiming to translate scientific discoveries into effective clinical applications. Columbia University is dedicated to maintaining the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants while contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported